Press release
North American Biotechnology Market: Analysis Report, Share, Trends and Overview 2021-2027
North American biotechnology market is projected to grow at a significant CAGR of 7.3% during the forecast period. The increasing popularity of 3D cell culture in drug discovery, cancer treatment, vaccine production has promoted the funding of cell-based research, however, the funds required for cell-based research is very high due to which funding for these researches has been encouraged in a very few of the developed nations such as the US. The NIH is the largest source of funding for biomedical research globally. More than 83% of the NIH funds are distributed through competitive grants to over 300,000 scientists employed at universities, medical schools, and other research institutions in all 50 states.A full report of North American Biotechnology Market is available at: https://www.omrglobal.com/industry-reports/north-american-biotechnology-market
NIH the largest federal agency spent half of the biomedical funds on cell-based research. Research supported by NIH has also extended the understanding of the molecular roots of various cancers and led to important awareness as to how microbial communities affect a range of chronic diseases including obesity and diabetes. It has led to the development of innovative technologies and created entirely new global industries. Investment in biomedical research funded by NIH has supported discoveries that reduced mortality and disability from polio, heart disease, and cancer, prolonging life and reducing suffering. NIH-funded research is continuing to produce the awareness that is needed for improvements in health care in the future.
To learn more about this report Request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-biotechnology-market
Market Coverage
• Study Period- 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segments Covered- By Type
• Countries Covered- US and Canada
• Key Companies Profiled- Amgen Inc., Novo Nordisk A/S, CSL Ltd., Bristol-Myers Squibb Co., AstraZeneca PLC, Merck & Co., Inc., Johnson & Johnson Services Inc., and Pfizer Inc.
Key questions addressed by the report
• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID
o Most affected region/segment
o Recommendations
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
North American Biotechnology Market – Segmentation
By Type
• Healthcare
• Crop Production and Agriculture
• Industrial
• Natural Resources & Environment
• Others (Bioinformatics)
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-biotechnology-market
North American Biotechnology Market – Segmentation by Region
• US
• Canada
Company Profiles
• Abbott Laboratories
• AbbVie Inc.
• ADOCIA
• Alere Inc.
• Alkermes PLC
• Amgen Inc.
• AstraZeneca PLC
• BIOCAD
• Biogen Inc.
• Bristol-Myers Squibb Co.
• CSL Ltd.
• F. Hoffmann La-Roche Ltd.
• Galapagos NV
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Miltenyi Biotec B.V. & Co. KG
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North American Biotechnology Market: Analysis Report, Share, Trends and Overview 2021-2027 here
News-ID: 2478199 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for NIH
AICUP to Congress: NIH/NSF Research Fuels Pennsylvania's Economy
"AICUP TO CONGRESS: NIH/NSF RESEARCH FUELS PENNSYLVANIA'S ECONOMY"
Letter to Pennsylvania Congressional Delegation on Behalf of 85 Independent Nonprofit Colleges and Universities Spotlights the Crucial Role of Research Funding in Modern Life, American Prosperity
For Immediate Release …
Creative Biolabs Shines at the 2024 NIH Research Festival: Showcasing Antibody S …
Creative Biolabs made a splash at the 2024 NIH Research Festival, held from Sept. 23 to 25, as they highlighted their groundbreaking work in antibody discovery and development.
New York, USA - October 9, 2024 - The festival, which featured scientific lectures, poster presentations, and workshops, was a vibrant hub of knowledge exchange, and Creative Biolabs took center stage in presenting their cutting-edge antibody solutions.
Image: https://www.getnews.info/uploads/b920cc86d613e54736218c29e7f29b5b.jpg
One of the standout technologies on…
Omnix Medical Receives NIH Grant for the Development of its Novel Antimicrobial …
-- Funding supports unique approach for fighting multi-drug resistant Acinetobacter baumannii (AB)
-- Clinical trial preparations of OMN6 under way
JERUSALEM, Israel, August 31, 2021 -- Omnix Medical, a Jerusalem-based biopharmaceutical company developing next-generation anti-infectives for the treatment of life-threatening infections, has received a grant by the U.S. National Institutes of Health (NIH) for the development of its first-in-class antimicrobial peptide OMN6 targeting Acinetobacter baumannii (AB). Acinetobacter baumannii are multi-drug resistant…
The National Institutes of Health (NIH) Awards Adelphi University Professors Nea …
The National Institutes of Health (NIH) has awarded Adelphi University Associate Professors Brian Stockman, Ph.D. and Melissa VanAlstine-Parris, Ph.D., both in the Department of Chemistry, a federal grant for $310,934. One of the main goals of the project is to immerse undergraduate students into cutting-edge scientific research including hands-on use of NMR spectroscopy instrumentation, medicinal chemistry and Trichomonas vaginalis cell biology. The award became active on June 1, 2017 and…
BARDA, NIH and Janssen to Present on Antimicrobial Resistance at Superbugs USA t …
SMi are delighted to announce the expansion of their antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA, complementing the Group’s Superbugs & Superdrugs European conference which has been running for the past 18 years.
With pending confirmations from PAHO/WHO and Astra Zeneca, SMi Group have worked closely with a panel of speakers to present an agenda that will look to address key issues…
Dr. James Gulley - NCI, NIH to speak at the Cancer Immunotherapy Congress in Bos …
Dr. James Gulley, an internationally recognized expert in cancer immunotherapy has joined the speaker panel for the Cancer Immunotherapy Congress organized by Markets and Markets Conferences. The congress scheduled for 19th – 20th May 2016 in Boston, USA, will gather scientists, academicians and professionals from Pharmaceutical, Bio-pharmaceutical, Bio-technology companies and Research institutes working in Drug Discovery, Drug Screening, Oncology R&D, Cancer Immunotherapy/ Immuno-oncology and Immunotherapy R&D.
Dr. Gulley serves within…